GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                            
                            
                            
                                 Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: NSC61610 is a LANCL2 modulator that was discovered using high-throughput, structure-based virtual screening [2]. It has a poor drug-like profile, passing only one of the six Lipinski-like filters. Omilancor was designed as an improved version of NSC61610 (it passes three of the Lipinski rules).
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Immunopharmacology Comments | 
| NSC61610 is a LANCL2 modulator that exhibits anti-inflammatory activity [2]. It ameliorates disease activity and inflammatory lesions in vivo, in the mouse DSS-induced colitis model. |